Aytu biopharma completes $15 million debt refinancing

Englewood, co / accesswire / january 31, 2022 / aytu biopharma, inc. (nasdaq:aytu), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that it has entered into an agreement with the avenue venture opportunities fund, l.p., an affiliate of avenue capital group, to refinance the company's existing senior secured loan facility.
AYTU Ratings Summary
AYTU Quant Ranking